FDA Regulation
FDA proposes Class II classification with special controls for high‑throughput DNA sequencing test for hereditary cancer risk
The U.S. Food and Drug Administration is moving to place a high‑throughput DNA sequencing system used to assess hereditary cancer predisposition into Class II, meaning it will be subject to special controls. The agency…
1 source4 claims checked6h ago
4 unverifiable
Biblical perspectiveINSUFFICIENT CONTEXT
Full analysis